Aminoglycoside ototoxicity: Prevention in sight?

Otolaryngology - Head and Neck Surgery

Volumn 118, Issue 5, 1998, Pages 674-677

  Schacht, J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CHELATING AGENT;

ANTIBIOTIC THERAPY; HUMAN; INNER EAR DISEASE; IRON CHELATION; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; REVIEW; VESTIBULAR DISORDER;

EID: 0031953870     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(98)70239-6     Document Type: Article

References (22)

1. A Schatz E Bugie SA. Waksman Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria Proc Soc Exp Biol Med 55 1944 66 69
2. HC Hinshaw WH. Feldman Streptomycin in treatment of clinical tuberculosis: a preliminary report Proc Mayo Clinic 20 1945 313 318
3. SL Garetz J. Schacht Ototoxicity: of mice and men TR VanDeWater AN Popper RR Fay Handbook of auditory research. Vol. VII. Clinical aspects of hearing. 1996 Springer-Verlag New York 116 154
4. WE. Fee Aminoglycoside ototoxicity in the human Laryngoscope 40 1980 1 19
5. SA Lerner BA Schmitt R Seligsoh GJ. Matz Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin Am J Med 80 1986 98 104
6. RE Brummett RB. Morrison The incidence of aminoglycoside antibiotic-induced hearing loss Arch Otolaryngol Head Neck Surg 116 1990 406 410
7. DM. Fu Survey of 1583 deaf mutes Qinghai Med J 1 1985 22 23
8. YF. Lu Cause of 611 deaf mutes in schools for deaf children in Shanghai Shanghai Med J 10 1987 159
9. RW Shafer KD Chirgwin AE Glatt MA Dahdouh SH Landesman B. Suster HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS AIDS 5 1991 399 406
10. J. Schacht Biochemical basis of aminoglycoside ototoxicity Otolaryngol Clin North Am 26 1993 845 856
11. SL Garetz DJ Rhee J. Schacht Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro Hear Res 77 1994 75 80
12. E Priuska J. Schacht Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex Biochem Pharmacol 50 1995 1749 1752
13. SA Crann J. Schacht Activation of aminoglycoside antibiotics to cytotoxins Audiol Neuro Otol 1 1996 80 85
14. B-B Song J. Schacht Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo Hear Res 94 1996 87 93
15. DY Dawson SE Hudson PK. Mascharak Oxygen transfer reactions by synthetic analogues of iron-bleomycin J Inorg Biochem 47 1992 109 117
16. B Halliwell JMC. Gutteridge Oxygen free radicals and iron in relation on biology and medicine: some problems and concepts Arch Biochem Biophys 246 1986 501 514
17. P. Federspil Antibiotikaschäden des Ohres 1979 Barth Leipzig 86 89
18. C. Hershko Iron chelators in medicine Molec Aspects Med 13 1992 113 165
19. H Kanno S Yamanobe LP. Rybak The ototoxicity of deferoxamine mesylate Am J Otolaryngol 16 1995 148 152
20. CM Peterson JH Graziano RW Grady Chelation therapy in β-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid Exp Hematol 7 1979 74 80
21. PD Walker SV. Shah Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats J Clin Invest 81 1988 334 341
22. RA Pearce RJ Finley RA Mustard JH. Duff 2,3- Dihydroxybenzoic acid: effect on mortality rate in a septic rat model Arch Surg 120 1985 937 940